Buprenorphine / Naloxone

Known as: Buprenorphine-Naloxone Drug Combination, Buprenorphine-Naloxone, Buprenorphine Naloxone Combination 
A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESIC with naloxone, a NARCOTIC ANTAGONIST to reduce the potential for… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
CONTEXT No randomized trials have examined treatments for prescription opioid dependence, despite its increasing prevalence… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND Having opioid dependence and HIV infection are associated with poor HIV-related treatment outcomes. METHODS HIV… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
By employing transcranial magnetic stimulation (TMS) in combination with high-density electroencephalography (EEG), we recently… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
CONTEXT The usual treatment for opioid-addicted youth is detoxification and counseling. Extended medication-assisted therapy may… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
By reducing the fear of a hostile takeover, business combination (BC) laws weaken corporate governance and create more… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Prescription opioid dependence is increasing, but treatment outcomes with office-based buprenorphine/naloxone among these… (More)
  • table 1
  • table 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND The optimal level of counseling and frequency of attendance for medication distribution has not been established for… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2003
Review
2003
The unique pharmacology of buprenorphine at the mu-opioid receptor (i.e. high affinity, low intrinsic activity and slow… (More)
Is this relevant?
Review
2000
Review
2000
In 1963, Professor Vincent P. Dole at the Rockefeller University formed a small team to develop a pharmacotherapy for the… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND Q fever endocarditis, caused by Coxiella burnetii, is fatal in 25% to 60% of patients. Currently, treatment with a… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?